TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 19 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $658,000 | +402.3% | 37,485 | +26.2% | 0.02% | +41.7% |
| Q2 2017 | $131,000 | -9.7% | 29,700 | +26.4% | 0.01% | -14.3% |
| Q1 2017 | $145,000 | +9.0% | 23,500 | 0.0% | 0.01% | -12.5% |
| Q4 2016 | $133,000 | +2116.7% | 23,500 | +5775.0% | 0.02% | +1500.0% |
| Q3 2016 | $6,000 | +200.0% | 400 | +100.0% | 0.00% | – |
| Q2 2016 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 206,800 | $36,314,000 | 8.27% |
| Fairmount Funds Management LLC | 886,281 | $15,563,000 | 5.66% |
| FRAZIER MANAGEMENT LLC | 3,123,107 | $54,984,000 | 4.40% |
| ACT CAPITAL MANAGEMENT, LLC | 466,000 | $8,183,000 | 4.24% |
| RAMIUS ADVISORS LLC | 338,042 | $5,936,000 | 3.54% |
| Western Standard LLC | 265,355 | $4,660,000 | 2.65% |
| HAVENS ADVISORS LLC | 109,000 | $1,914,000 | 2.30% |
| Crabel Capital Management, LLC | 423,490 | $7,436,000 | 2.29% |
| S. MUOIO & CO. LLC | 160,000 | $2,810,000 | 2.16% |
| Omni Partners US LLC | 2,366,824 | $41,561,000 | 2.13% |